Quantcast
Home » Topics » Cipro

Supreme Court won’t review drug patent deal

WASHINGTON (Reuters) – The Supreme Court let stand a ruling that drug companies can pay rivals to delay production of generic drugs without violating federal antitrust laws. The justices refused to review a U.S. appeals court ruling that upheld the dismissal of a legal challenge to a deal between Bayer…

Google+